Early research (Phase 1)Study completedNCT00739453What this trial is testingDose-escalation Study of OSI-906 and Erlotinib (Tarceva®)Who this might be right forAdvanced Solid Tumors Astellas Pharma Inc 95
Early research (Phase 1)Study completedNCT02897375What this trial is testingPalbociclib With Cisplatin or Carboplatin in Advanced Solid TumorsWho this might be right forSolid NeoplasmStage III Pancreatic CancerStage IIIA Breast Cancer+14 more Emory University 71
Testing effectiveness (Phase 2)WithdrawnNCT05234606What this trial is testingA Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid TumorsWho this might be right forUrothelial CarcinomaTriple Negative Breast CancerNon-small Cell Lung Cancer+2 more Silverback Therapeutics
Early research (Phase 1)Study completedNCT03811652What this trial is testingA Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid TumorsWho this might be right forNon Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more MedImmune LLC 8
Early research (Phase 1)Looking for participantsNCT06307925What this trial is testingA Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor HC Biopharma Inc. 122
Early research (Phase 1)Study completedNCT03509012What this trial is testingImmunotherapy in Combination With Chemoradiation in Patients With Advanced Solid TumorsWho this might be right forCarcinoma, Squamous Cell of Head and NeckCarcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma AstraZeneca 105
Early research (Phase 1)Looking for participantsNCT06475937What this trial is testingDM001 in Patients With Advanced Solid TumorsWho this might be right forBreast NeoplasmsCarcinoma, Non-Small-Cell LungSolid Carcinoma Xadcera Biopharmaceutical (Suzhou) Co., Ltd. 128
Early research (Phase 1)Study completedNCT00514306What this trial is testingStudy of Intermittent OSI-906 DosingWho this might be right forAdvanced Solid Tumors Astellas Pharma Inc 79
Early research (Phase 1)Ended earlyNCT05317078What this trial is testingSafety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor IndicationsWho this might be right forNon-squamous Non-small Cell Lung CancerEpithelial Ovarian CancerClaudin 6-positive Advanced/Metastatic Malignant Solid Tumors Amgen 3
Early research (Phase 1)Study completedNCT02457793What this trial is testingThe Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forNon-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Metastatic Non Small Cell Lung Cancer, Metastatic Cancers, Melanoma Genentech, Inc. 24
Early research (Phase 1)Active Not RecruitingNCT05752552What this trial is testingStudy to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid TumoursWho this might be right forAdult Solid TumorAdvanced Solid TumorRefractory Tumor+4 more DeuterOncology 25
Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Early research (Phase 1)Active Not RecruitingNCT02817633What this trial is testingTSR-022 in Participants With Advanced Solid Tumors (AMBER)Who this might be right forNeoplasms Tesaro, Inc. 463
Testing effectiveness (Phase 2)Ended earlyNCT06171789What this trial is testingPRO1107 in Patients With Advanced Solid TumorsWho this might be right forEndometrial CancerOvarian CancerTriple Negative Breast Cancer+3 more Genmab 33
Early research (Phase 1)Active Not RecruitingNCT02495896What this trial is testingRecombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid TumorsWho this might be right forHead and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more University of Southern California 61
Early research (Phase 1)Study completedNCT02835833What this trial is testingStudy of Nintedanib Plus Bevacizumab in Advanced Solid TumorsWho this might be right forRenal Cell CarcinomaColorectal AdenocarcinomaNon-squamous Non-small Cell Lung Cancer+2 more University of Alabama at Birmingham 21
Testing effectiveness (Phase 2)Looking for participantsNCT06172478What this trial is testingHER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorMelanomaHead and Neck Cancer+11 more Daiichi Sankyo 740
Early research (Phase 1)Active Not RecruitingNCT05653882What this trial is testingA Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid TumorsWho this might be right forSolid TumorNon Small Cell Lung CancerMelanoma+2 more Asher Biotherapeutics, Inc. 552
Early research (Phase 1)Ended earlyNCT01891669What this trial is testingPF-06263507 In Patients With Advanced Solid TumorsWho this might be right forNeoplasmsCarcinoma, Non Small Cell LungBreast Neoplasms+1 more Pfizer 26
Early research (Phase 1)Ended earlyNCT04261439What this trial is testingA Phase I/Ib Study of NIZ985 Alone and in Combination With SpartalizumabWho this might be right forIn Escalation: All Patients With Solid Tumors and LymphomaIn Expansion: Melanoma, Non-small Cell Lung Cancer Novartis Pharmaceuticals 60